Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation.
There is strong evidence that points to excess dietary salt as a major factor contributing to the development of hypertension. Salt sensitivity is associated with glucose intolerance and insulin resistance in both animal models and humans. In insulin resistance, impaired glucose metabolism leads to elevated endogenous aldehydes which bind to vascular calcium channels, increasing cytosolic [Ca2+]i and blood pressure. In an insulin resistant animal model of hypertension, spontaneously hypertensive rats (SHRs), dietary supplementation with lipoic acid lowers tissue aldehydes and plasma insulin levels and normalizes blood pressure. The objective of this study is to examine the effects of a high salt diet on tissue aldehydes, cytosolic [Ca2+]i and blood pressure in WKY rats and to investigate whether dietary supplementation with lipoic acid can prevent a salt induced increase in blood pressure. Starting at 7 weeks of age, WKY rats were divided into three groups of six animals each and treated for 10 weeks with diets as follows: WKY-normal salt (0.7% NaCl); WKY-high salt (8% NaCl); WKY-high salt + lipoic acid (8% NaCl diet + lipoic acid 500 mg/Kg feed). At completion, animals in the high salt group had elevated systolic blood pressure, platelet [Ca2+]i, and tissue aldehyde conjugates compared with the normal salt group and showed smooth muscle cell hyperplasia in the small arteries and arterioles of the kidneys. Dietary alpha-lipoic acid supplementation in high salt-treated WKY rats normalized systolic blood pressure and cytosolic [Ca2+]i and aldehydes in liver and aorta. Kidney aldehydes and renal vascular changes were attenuated, but not normalized.
Vasdev
Sudesh
S
Department of Medicine and Laboratory Medicine, Health Sciences Centre, Memorial University of Newfoundland, St. John's Newfoundland, Canada. svasdev@mun.ca
Gill
Vicki
V
Longerich
Linda
L
Parai
Sushil
S
Gadag
Veeresh
V
D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001794:Blood Pressure; D001835:Body Weight; D002118:Calcium / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D019587:Dietary Supplements; D006973:Hypertension / Q000139:chemically induced* / Q000517:prevention & control*; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000098:blood supply / Q000187:drug effects; D009929:Organ Size; D051381:Rats; D011921:Rats, Inbred WKY; D012492:Salts / Q000494:pharmacology*; D008063:Thioctic Acid / Q000378:metabolism / Q000494:pharmacology*; D013997:Time Factors
D000447:Aldehydes; D000975:Antioxidants; D007328:Insulin; D012492:Salts; D008063:Thioctic Acid; D002118:Calcium